Papaverine Hydrochloride Injection, Solution
Product Images NDC 72516-024

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Papaverine Hydrochloride (NDC 72516-024). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure01)

Chemical structure of Papaverine Hydrochloride, showing the molecular arrangement with methoxy groups and the hydrochloride component.*

FDA Label Image

Caton-pack Of 25 (Carton 25)

Packaging label for Papaverine Hydrochloride Injection, USP, 60 mg per 2 mL vial (30 mg/mL), for single use only. The label indicates a carton containing 25 vials of 2 mL each. It includes storage instructions to protect from light and maintain at controlled temperatures. The product is manufactured for Oryza Pharmaceuticals Inc. and carries the NDC 72516-024-25.*

FDA Label Image

Carton- Pack Of 10 (Carton 10)

Packaging label for Papaverine Hydrochloride Injection, USP 60 mg/2 mL (30 mg/mL) by Oryza Pharmaceuticals Inc. The label indicates a carton containing ten 2 mL vials for intravenous use. It includes storage instructions, a warning to protect from light, and states the product is for single use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.